SheerVision, Inc. (SVSO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2009 | 155.72 Thousand USD | -9.04% |
| 2008 | 171.21 Thousand USD | -81.29% |
| 2007 | 915.09 Thousand USD | -27.46% |
| 2006 | 1.26 Million USD | 1849.82% |
| 2005 | 64.69 Thousand USD | -14.51% |
| 2004 | 75.67 Thousand USD | -13.5% |
| 2003 | 87.49 Thousand USD | 190.36% |
| 2002 | 30.13 Thousand USD | 75.07% |
| 2001 | 17.21 Thousand USD | 34.94% |
| 2000 | 12.75 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2010 Q1 | 33.3 Thousand USD | -27.97% |
| 2010 Q3 | 13.08 Thousand USD | -91.31% |
| 2010 Q2 | 150.56 Thousand USD | 352.16% |
| 2009 Q3 | 59.24 Thousand USD | -50.55% |
| 2009 Q1 | 69.58 Thousand USD | 227.73% |
| 2009 Q4 | 46.23 Thousand USD | -21.97% |
| 2009 Q2 | 119.81 Thousand USD | 72.19% |
| 2009 FY | 155.72 Thousand USD | -9.04% |
| 2008 Q3 | 89.68 Thousand USD | -42.54% |
| 2008 Q4 | -54.47 Thousand USD | -160.74% |
| 2008 FY | 171.21 Thousand USD | -81.29% |
| 2008 Q1 | 20.1 Thousand USD | 273.05% |
| 2008 Q2 | 156.09 Thousand USD | 676.5% |
| 2007 Q3 | 193.48 Thousand USD | -51.65% |
| 2007 Q2 | 400.2 Thousand USD | 20.19% |
| 2007 Q1 | 332.98 Thousand USD | -34.83% |
| 2007 FY | 915.09 Thousand USD | -27.46% |
| 2007 Q4 | -11.61 Thousand USD | -106.0% |
| 2006 Q1 | 4666.00 USD | -34.99% |
| 2006 Q2 | 242.78 Thousand USD | 5103.21% |
| 2006 Q3 | 214.75 Thousand USD | -11.54% |
| 2006 FY | 1.26 Million USD | 1849.82% |
| 2006 Q4 | 510.99 Thousand USD | 137.94% |
| 2005 FY | 64.69 Thousand USD | -14.51% |
| 2005 Q1 | 22.31 Thousand USD | 27.77% |
| 2005 Q3 | 8213.00 USD | -50.82% |
| 2005 Q2 | 16.7 Thousand USD | -25.17% |
| 2005 Q4 | 7177.00 USD | -12.61% |
| 2004 Q4 | 17.46 Thousand USD | -40.23% |
| 2004 Q1 | 18.22 Thousand USD | 6.3% |
| 2004 Q2 | 11.09 Thousand USD | -39.13% |
| 2004 FY | 75.67 Thousand USD | -13.5% |
| 2004 Q3 | 29.22 Thousand USD | 163.51% |
| 2003 FY | 87.49 Thousand USD | 190.36% |
| 2003 Q4 | 17.14 Thousand USD | -5.63% |
| 2003 Q3 | 18.16 Thousand USD | -3.31% |
| 2003 Q2 | 18.78 Thousand USD | 1842.61% |
| 2003 Q1 | 967.00 USD | -96.38% |
| 2002 Q2 | 7471.00 USD | 672.6% |
| 2002 Q4 | 26.74 Thousand USD | 148.49% |
| 2002 FY | 30.13 Thousand USD | 75.07% |
| 2002 Q1 | 967.00 USD | -92.48% |
| 2002 Q3 | 10.76 Thousand USD | 44.08% |
| 2001 Q4 | 12.86 Thousand USD | 94.17% |
| 2001 Q3 | 6625.00 USD | 87.73% |
| 2001 Q2 | 3529.00 USD | -26.14% |
| 2001 Q1 | 4778.00 USD | 109.93% |
| 2001 FY | 17.21 Thousand USD | 34.94% |
| 2000 Q3 | 8783.00 USD | 521.59% |
| 2000 Q4 | 2276.00 USD | -74.09% |
| 2000 Q1 | 1258.00 USD | -3.16% |
| 2000 FY | 12.75 Thousand USD | 0.0% |
| 2000 Q2 | 1413.00 USD | 12.32% |
| 1999 Q4 | 1299.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 86.624% |
| Ansell Limited | 129.3 Million USD | 99.88% |
| Ansell Limited | 129.3 Million USD | 99.88% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 99.5% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 109.759% |
| Psykey, Inc. | -797.5 Thousand USD | 119.527% |
| ConvaTec Group Plc | 262.7 Million USD | 99.941% |
| ConvaTec Group Plc | 262.7 Million USD | 99.941% |
| Encision Inc. | -640.78 Thousand USD | 124.302% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 209.813% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 241.659% |
| Innovative MedTech Inc. | -4.27 Million USD | 103.644% |
| LifePoint, Inc. | -7.49 Million USD | 102.078% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 102.403% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 52.81% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 226.72% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 133.326% |
| SmileDirectClub, Inc. | -241.15 Million USD | 100.065% |
| Sector 10, Inc. | -39.84 Thousand USD | 490.839% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 99.951% |
| United Health Products, Inc. | -2.42 Million USD | 106.418% |
| Vasamed, Inc. | 4.74 Million USD | 96.716% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 106.788% |
| Yubo International Biotech Limited | -1.2 Million USD | 112.921% |